Disease screening
will be as easy as breathing.

Our technology will screen for disease through a simple breath test.

Our most recent research demonstrated early-stage breast cancer detection in the breath with 88.2% accuracy, while also identifying that the results were independent of breast tissue density. This groundbreaking research was conducted by Dr. Farah Naz, using Breathe BioMedical’s technology, and was published as an online abstract at the ASCO 2023 Annual Meeting.
View 2023 ASCO Breast Cancer AbstractView 2022 ASCO Breast Cancer AbstractView Journal of Breath Research PaperView ASCO Lung Cancer AbstractView Breath Biopsy PosterView COVID-19 Pneumonia Abstract
Early disease detection is key to helping people live longer, healthier lives. Our technology could make screening for diseases easier, faster and more accessible than ever before.

Just breathe®


Biomarkers in Breath

When we exhale, there’s much more in our breath than most would ever suspect. Find out how we’re using machine learning technology to change how and when we screen and track disease.


In the News